Compile Data Set for Download or QSAR
maximum 50k data
Found 41 with Last Name = 'ashida' and Initial = 'y'
TargetProtein kinase C delta type(Mus musculus)
Ehime University

Curated by ChEMBL
LigandPNGBDBM50186737(CHEMBL3822902)
Affinity DataKi:  370nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta C1B domain in CD-1 mouse brain cytosol incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein kinase C delta type(Mus musculus)
Ehime University

Curated by ChEMBL
LigandPNGBDBM50186730(CHEMBL3823933)
Affinity DataKi:  2.90E+3nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta C1B domain in CD-1 mouse brain cytosol incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein kinase C delta type(Mus musculus)
Ehime University

Curated by ChEMBL
LigandPNGBDBM50186731(CHEMBL3823752)
Affinity DataKi: >2.00E+4nMAssay Description:Inhibition of [3H]PDBu binding to PKCdelta C1B domain in CD-1 mouse brain cytosol incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50228336(CHEMBL71879)
Affinity DataIC50:  2.10nMAssay Description:In vitro inhibition of Escherichia coli dihydrofolate reductase.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109264(US8609710, 40)
Affinity DataIC50:  2.60nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50005097(7-(4-Fluoro-phenyl)-7-(3-formyl-6-hydroxy-2,4,5-tr...)
Affinity DataIC50:  4.40nMAssay Description:Compound was evaluated for its ability to inhibit specific binding of [3H]-U-46,619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platel...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109265(US8609710, 35 (2S,4R form))
Affinity DataIC50:  5.10nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109258(US8609710, 34 (2S,4S form))
Affinity DataIC50:  5.40nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109254(US8609710, 25)
Affinity DataIC50:  7nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50279755(7-Phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,...)
Affinity DataIC50:  7.40nMAssay Description:In vitro concentration of the compound that reduced specific binding of [3H]-U-440619 to guinea pig platelet receptor, TXA2 by 50%More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109256(US8609710, 33)
Affinity DataIC50:  7.5nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109252(US8609710, 15 (2S form))
Affinity DataIC50:  7.80nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109253(US8609710, 24)
Affinity DataIC50:  8.10nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109238(US8609710, 2)
Affinity DataIC50:  8.30nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109239(US8609710, 3)
Affinity DataIC50:  8.80nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109263(US8609710, 39)
Affinity DataIC50:  9.30nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109262(US8609710, 38)
Affinity DataIC50:  9.80nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109260(US8609710, 36)
Affinity DataIC50:  10nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109249(US8609710, 13)
Affinity DataIC50:  12nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109250(US8609710, 14)
Affinity DataIC50:  13nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109240(US8609710, 4)
Affinity DataIC50:  14nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109247(US8609710, 11)
Affinity DataIC50:  14nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109245(US8609710, 9)
Affinity DataIC50:  18nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109244(US8609710, 8)
Affinity DataIC50:  19nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109261(US8609710, 37)
Affinity DataIC50:  19nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50005108(7-(3-Formyl-6-hydroxy-2,4,5-trimethyl-phenyl)-7-ph...)
Affinity DataIC50:  20nMAssay Description:Compound was evaluated for its ability to inhibit specific binding of [3H]-U-46,619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platel...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109237(US8609710, 1)
Affinity DataIC50:  21nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109242(US8609710, 6)
Affinity DataIC50:  21nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109246(US8609710, 10)
Affinity DataIC50:  21nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109255(US8609710, 26)
Affinity DataIC50:  21nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109248(US8609710, 12)
Affinity DataIC50:  25nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109243(US8609710, 7)
Affinity DataIC50:  26nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50005102(7-(4-Fluoro-phenyl)-7-(4-formyl-2-hydroxy-3,5,6-tr...)
Affinity DataIC50:  30nMAssay Description:Compound was evaluated for its ability to inhibit specific binding of [3H]-U-46,619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platel...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50292409((Z)-7-((1R,4S,5S,6R)-6-((S,E)-3-hydroxyoct-1-enyl)...)
Affinity DataIC50:  31nMAssay Description:In vitro concentration of the compound that reduced specific binding of [3H]-U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109257(US8609710, 34 (2R,4S form))
Affinity DataIC50:  34nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109241(US8609710, 5)
Affinity DataIC50:  35nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109251(US8609710, 15 (2R form))
Affinity DataIC50: >100nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Daiichi Sankyo

US Patent
LigandPNGBDBM109259(US8609710, 35 (2R,4R form))
Affinity DataIC50: >100nMAssay Description:Enzyme inhibition assay using TAFIa.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50005113(7-(2,5-Dihydroxy-3,4,6-trimethyl-phenyl)-7-(4-fluo...)
Affinity DataIC50:  200nMAssay Description:Compound was evaluated for its ability to inhibit specific binding of [3H]-U-46,619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platel...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50228337(CHEMBL71921)
Affinity DataIC50:  210nMAssay Description:In vitro inhibition of rat liver dihydrofolate reductase.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetThromboxane A2 receptor(Homo sapiens (Human))
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50005098(7-(4-Fluoro-phenyl)-7-(2,4,5-trimethyl-3,6-dioxo-c...)
Affinity DataIC50:  1.40E+3nMAssay Description:Compound was evaluated for its ability to inhibit specific binding of [3H]-U-46,619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platel...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed